ProShare Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,033
| Closed | -$907K | – | 2302 |
|
|
2024
Q3 | $907K | Buy |
13,033
+2,828
| +28% | +$194K | ﹤0.01% | 845 |
|
|
2024
Q2 | $686K | Sell |
10,205
-2,547
| -20% | -$172K | ﹤0.01% | 841 |
|
|
2024
Q1 | $880K | Buy |
12,752
+4,517
| +55% | +$305K | ﹤0.01% | 822 |
|
|
2023
Q4 | $512K | Buy |
8,235
+1,860
| +29% | +$104K | ﹤0.01% | 1024 |
|
|
2023
Q3 | $358K | Sell |
6,375
-7
| -0.1% | -$394 | ﹤0.01% | 1113 |
|
|
2023
Q2 | $322K | Buy |
6,382
+612
| +11% | +$32.6K | ﹤0.01% | 1231 |
|
|
2023
Q1 | $315K | Sell |
5,770
-537
| -9% | -$31.4K | ﹤0.01% | 1186 |
|
|
2022
Q4 | $394K | Buy |
6,307
+903
| +17% | +$59.9K | ﹤0.01% | 1084 |
|
|
2022
Q3 | $381K | Buy |
5,404
+128
| +2% | +$8.83K | ﹤0.01% | 1020 |
|
|
2022
Q2 | $299K | Sell |
5,276
-3,318
| -39% | -$182K | ﹤0.01% | 1222 |
|
|
2022
Q1 | $537K | Sell |
8,594
-1,420
| -14% | -$76.5K | ﹤0.01% | 1244 |
|
|
2021
Q4 | $561K | Buy |
10,014
+4,140
| +70% | +$253K | ﹤0.01% | 1368 |
|
|
2021
Q3 | $382K | Sell |
5,874
-4,928
| -46% | -$336K | ﹤0.01% | 1378 |
|
|
2021
Q2 | $685K | Buy |
10,802
+2,717
| +34% | +$160K | ﹤0.01% | 1288 |
|
|
2021
Q1 | $484K | Buy |
8,085
+1,388
| +21% | +$75.5K | ﹤0.01% | 1463 |
|
|
2020
Q4 | $334K | Sell |
6,697
-3,382
| -34% | -$159K | ﹤0.01% | 1542 |
|
|
2020
Q3 | $514K | Sell |
10,079
-312
| -3% | -$13K | ﹤0.01% | 935 |
|
|
2020
Q2 | $365K | Buy |
+10,391
| New | +$358K | ﹤0.01% | 1112 |
|
|
2020
Q1 | – | Sell |
-9,459
| Closed | -$262K | – | 1641 |
|
|
2019
Q4 | $262K | Buy |
+9,459
| New | +$226K | ﹤0.01% | 1426 |
|
Other funds holding AXNX
ProShare Advisors's AXNX Position: Q4 2024 in Review
ProShare Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 13,033 shares — an estimated $907K sold.
ProShare Advisors first reported a position in AXNX in Q4 2019 and held it in 19 quarters. The position peaked at $907K in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.
- ProShare Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- ProShare Advisors sold 13,033 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $907K.
- ProShare Advisors first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 19 quarters.
- ProShare Advisors's Axonics, Inc. Common Stock position peaked at $907K in Q3 2024.
- 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.
Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.